EP 2531179 A1 20121212 - PHARMACEUTICAL COMPOSITION COMPRISING N-(2-CHLORO-6-METHYLPHENYL)-2-[[6-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-2-METHYL-4-PYRIMIDINYL]AMINO]-5-THIAZOLECARBOXAMID
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING N-(2-CHLORO-6-METHYLPHENYL)-2-[[6-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-2-METHYL-4-PYRIMIDINYL]AMINO]-5-THIAZOLECARBOXAMID
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT N-(2-CHLORO-6-METHYLPHENYL)-2-+AFSAWW-6-+AFS-4-(2-HYDROXYETHYL)-1-PIPERAZINYL+AF0--2-METHYL-4-PYRIMIDINYL+AF0-AMINO+AF0--5-THIAZOLECARBOXAMID
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT DU N-(2-CHLORO-6-MÉTHYLPHÉNYL)-2-[[6-[4-(2-HYDROXYÉTHYL)-1-PIPÉRAZINYL]-2-MÉTHYL-4-PYRIMIDINYL]AMINO]-5-THIAZOLECARBOXAMIDE
Publication
Application
Priority
- EP 10152690 A 20100204
- EP 2011051649 W 20110204
- EP 11702826 A 20110204
Abstract (en)
[origin: EP2359813A1] The present invention relates to a pharmaceutical composition comprising Dasatinib as active pharmaceutical ingredient.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/506 (2006.01)
CPC (source: EP)
A61K 9/2018 (2013.01); A61K 31/506 (2013.01); A61P 35/02 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2011095588A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 2359813 A1 20110824; CA 2788749 A1 20110811; EA 201201082 A1 20130329; EP 2531179 A1 20121212; JP 2013518860 A 20130523; WO 2011095588 A1 20110811
DOCDB simple family (application)
EP 10152690 A 20100204; CA 2788749 A 20110204; EA 201201082 A 20110204; EP 11702826 A 20110204; EP 2011051649 W 20110204; JP 2012551634 A 20110204